The evaluation of the anti‐cancer drug elesclomol that forms a redox‐active copper chelate as a potential anti‐tubercular drug-Reference-Cited by-同舟云学术

The evaluation of the anti‐cancer drug elesclomol that forms a redox‐active copper chelate as a potential anti‐tubercular drug

Published:2019-01-14 Issue:5 Volume:71 Page:532-538
ISSN:1521-6543
Container-title:IUBMB Life
language:en
Short-container-title:IUBMB Life

Author:

Ngwane Andile H.¹^ORCID,Petersen Ray‐Dean¹,Baker Bienyameen¹,Wiid Ian¹^ORCID,Wong Ho Ning²,Haynes Richard K.²

Affiliation:

1. DST‐NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health SciencesStellenbosch University Cape Town South Africa

2. Centre of Excellence for Pharmaceutical Sciences, Faculty of Health SciencesNorth‐West University Potchefstroom South Africa

Funder

North-West University

South African Medical Research Council

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Genetics,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iub.2002

Reference43 articles.

1. WHO. (2017)Global tuberculosis report 2017. World Health Organization Geneva Switzerland.